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InteractomicsSolid tumors require the formation of new blood vessels to support their growth, invasiveness and metastatic
potential. Tumor neovascularization is achieved by vasculogenesis from endothelial precursors and by sprouting
angiogenesis from preexisting vessels. The complex sequence of events driving these processes, including endo-
thelial activation, proliferation, migration and differentiation, is associated with ﬂuxes of ions, water and other
small molecules mediated by a great pool of ion channels and transporters (ICT). This ‘transportome’ is regulated
by environmental factors as well as intracellular signaling molecules. In turn, ICT play a prominent role in the
response to angiogenesis-related stimuli through canonical and ‘unconventional’ activities: indeed, there is an
increasing recognition of themultifunctionality of several ion channels that could also be annotated as receptors,
enzymes, scaffolding proteins, mechanical and chemical sensors.
The investigation of ICT structure and function has been far from the experimental oncology for long time and
these two domains converged only very recently. Furthermore, the systems biology viewpoint has not received
much attention in the biology of cancer transportome.Modulating angiogenesis by interference withmembrane
transport has a great potential in cancer treatment and the application of an ‘omics’ logicwill hopefully contribute
to the overall advancement in the ﬁeld.
This review is an attempt to apply the systems biology approach to the analysis of ICT involved in tumor
angiogenesis, with a particular focus on endothelial transportome diversity. This article is part of a Special
Issue entitled: Membrane channels and transporters in cancers.
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orino, Via Accademia Albertina1. Introduction
Over the last thirty years, much insight has been gained into the
central role of the endothelium in human health and disease [1]. Endo-
thelial cells (EC) represent a great evolutionary novelty in vertebrates
2648 L. Munaron / Biochimica et Biophysica Acta 1848 (2015) 2647–2656[2–5]: they line the blood vessel and act as a dynamic interface between
blood and tissues providing a powerful control system for blood pres-
sure and remodeling of vascular network [6]. Since the endothelium
can be a target or a causal factor of human disease, its assessment is a
valuable tool in clinical investigation [1]. The integrated evaluation
of endothelial function and dysfunction incorporating, for example,
coagulation, inﬂammatory, and vascular tone properties in normal
homeostasis and diseases led some authors to propose the concept of
‘endotheliome’ [7]. This term refers to endotheli-al form and function
as a whole (-ome): a key requirement is to forge a synthesis of the
array of endothelial vascular modiﬁcations in function of time and to
understand how they are required for a given function or dysfunction
to occur.
The formation of new blood vessels is required during tissue growth
and remodeling in order to provide adequate nutrients and oxygen and
overcome the basic surface/volume constraint in biological processes.
Neovascularization can occur through different mechanisms such as
vasculogenesis from endothelial precursors and sprouting angiogen-
esis [8]. During this process endothelial homeostasis is regulated by
pro- and anti-angiogenic factors: the response to these extracellular
stimuli depends, among the other proteins, on the plasma-membrane
transportome, the great and diversiﬁed tool of ion channels and trans-
porters (ICT) expressed in the plasmamembrane of EC [9]. Neovascular-
ization actually involves activation, proliferation, migration and
differentiation of EC and endothelial cell precursors (EPC): all these
events are associated with ﬂuxes of ions, water and other small mole-
cules mediated by a great variety of ICT [10,11]. The growing interest
on the contribution of ICT is clearly revealed by the huge number of
very recent reports and reviews focused on this topic and published in
a broad range of journals [10,12–17].
The transportome is ﬁnely regulated by a large pool of intracellular
and extracellular signals, respectively, including signaling/metabolic
pathways and soluble pro- and anti-angiogenic peptides, hormones, as
well as extracellular matrix components. In turn, they mediate theFig. 1. Conceptual scheme for an integrated view of membrane transportome and its role in tu
involving extracellular matrix (ECM), cytoskeleton and true intracellular signaling network. ER
folding and signaling molecules.vascular responsiveness to vasoactive stimuli. Intriguingly, this role is
not always played by their canonical activity: indeed, as discussed
below, a number of ion channels exhibit non-conductive functions
and could also be annotated as receptors, enzymes, scaffolding proteins,
mechanical and chemical sensors [18–23].2. ICT expression during normal and altered angiogenesis
Globally, themain aims for a systems biology of ICT in altered angio-
genesis should be 1) a clear deﬁnition of the endothelial transportome
and 2) a deep knowledge of its integration with cell signaling and
metabolome (the complete set of small molecule metabolites found
within a cell compartment) involved in patho-physiological neovascu-
larization: the latter issue is strictly related to protein interactomics
(Fig. 1).
To address the ﬁrst goal we need an exhaustive annotation of the
entire pool of ICT expressed by EC and EPC, their topological distribution
and a description of the great variability due to genetic and epigenetic
factors, including tissue microenvironment. The readout of this
approach would be particularly attractive for vascular biology due to
the great diversity found in normal and tumor-associated vessels and
endothelial cells [24,25].
Despite the importance and the increased utility of proteomic tools
in medical research for extending basic understanding in vascular biol-
ogy and for directing the delivery of therapeutic and imaging agents
in vivo, endothelial proteomics is only at its beginning. In addition, glob-
al ontology analyses are required to move beyond a simple list of pro-
teins and to understand better how they interact and function in a
given environment, providing a validation of a proteome generated
from large-scale mass spectrometry (MS) analysis. This would lead
to a better knowledge of the relationship of proteins in a functional
network, as well as to the detection of novel functions and pathways
in the given tissue [26].mor vascularization. The inset picture shows the ICT embodied in multiprotein complexes
M: ezrin, radixin, and moesin family of proteins. CAM: cell adhesion molecules. SM: scaf-
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named ‘plasma membranome’, e.g. the pool of proteins embedded in
plasma membrane lipid bilayer) by the use of standard large-scale
methods including MS-based strategies has been limited by problems
associated with extraction, solubilization, and identiﬁcation of intrinsic
membrane proteins in cells and tissues.Moreover, EC forma thinmono-
layer lining each blood vessel. They constitute a very small fraction of all
the cells in the tissue, making it difﬁcult to isolate pure EC plasmamem-
brane fractions for proteomics analysis using conventional sub-cellular
fractionation techniques. Although relatively simple to isolate from
tissue and grow in culture, EC requiremicroenvironmental components
to maintain their tissue-speciﬁc qualities and thus undergo undesired
phenotypic changes after isolation. Mass spectrometry (MS) measure-
ments and the use of multiple analytical methods can greatly expand
the comprehensiveness of endothelial proteomic proﬁling. However,
the inherent biases and variations in such data limit the quality of a
quantitative comparative analysis.
A recent comparative analysis of EC plasmamembranome employed
four different MS-based strategies involving 2-D and 3-D separation
[26]. It combines protein pre-fractionation via SDS-PAGE with in-gel
digestion to produce peptides separated by one- and two-dimensional
nano-HPLC before seamless and continuous MS analysis. Each method
used multiple replicate measurements to comprehensively identify
proteins, achieving a clear statistical deﬁnition of completeness that
allows meaningful comparisons. This approach greatly expanded the
EC plasma membranome to 1833 proteins of which nearly 30% are
membrane-embedded [26,27]. A further unbiased systems analysis
unraveled the related pathways and functions including cell surface
signaling networks, cytoskeleton organization, adhesion, membrane
trafﬁcking, metabolism, mechanotransduction, membrane fusion, and
vesicle-mediated transport [28].
Only a few studies incorporate proteomic analysis of freshly isolated
EC from healthy and altered tissues or conditions that mimic key angio-
genic variables, such as oxygen tension and shear stress [25].
We should take into account that the endothelium lining blood ves-
sels and surrounding stroma in tumors differs from normal one, but
only recently these differences have begun to be characterized at the
molecular level [29–31]. Since angiogenesis is required for physiological
processes, markers that distinguish normal and pathological vascula-
ture are needed in order to selectively deliver antiangiogenic agents to
diseased tissues minimizing the potential side effects. A proteomic
method has been developed to discover cell surface/secreted proteins,
as they represent key antibody therapeutic and biomarker opportuni-
ties [32]. It is based on ﬂow cytometric staining of vascular organs
with known endothelial markers and their puriﬁcation by cell sorting.
Upon cell surface protein capture and tryptic digestion, the resulting
proteolytic peptides are subjected to liquid chromatography–mass
spectrometry (LC/MS) to identify the proteins. The comparative analysis
revealed differences in the expression in different organs or conditions.
Tumor-derived endothelium obtained from the kidney, lung and colon
overexpresses more than one hundred of proteins when compared
with normal surrounding tissues [32]. Interestingly, ATP1B3 was
among the more differentially expressed cell surface tumor-speciﬁc
endothelial markers identiﬁed in this study. ATP1B3 belongs to the
family of Na+/K+-ATPases, integral membrane proteins responsible
for establishing and maintaining the electrochemical gradients
of Na+ and K+ ions across the plasma membrane. This enzyme is
composed of two subunits, a large catalytic α subunit and a smaller β
glycoprotein [33]. The β subunit regulates, through assembly of α/β
heterodimers, the number of Na+/K+ ATPases transported to the plas-
ma membrane. Recent studies indicate that the α- and β-subunits
might independently be involved in cellular functions other than ion
pumping [34]. For example, the β-subunit could play a role in cell–cell
adhesion. The amounts of the cell surface β-subunits increase when
the cell density becomes higher, whereas the amount of the α-subunit
does not change signiﬁcantly [34]. Further studies are needed to unveilthe functional outcome of ATP1B3 over-expression on tumor vascula-
ture [32].
Another proteomic work was undertaken on human telomerase-
immortalized dermal microvascular endothelial cells (TIME) in order
to identify key regulatory events at the protein level during tubular
morphogenesis in vitro [35]. Curiously, one of the VEGF-A-regulated
EC proteins was identiﬁed as chloride intracellular channel 4 (CLIC4).
The CLIC proteins have the unusual ability to translocate from the cyto-
plasm to various cell membranes and their overexpression promotes
plasmamembrane localizationwhere they act as functional anion chan-
nels. CLIC4 has also been shown to engage in complex formation with
cytoskeleton components such as actin, tubulin, and dynamin I. The
ability of CLIC4 tomodulate the activity of cell surface ICT in retinal pig-
ment epithelium–photoreceptor adhesion raises the possibility for a
similar role in vascular endothelium [36].
Although many compounds have entered clinical trials as modula-
tors of tumor angiogenesis, the conventional anti-angiogenic therapies
based on well established molecular targets such as VEGF, integrins
and angiopoietin, suppress neovascularization only transiently: they
suffer from the so-called ‘tumor escape phenomenon’, due to compen-
sating pathways that circumvent the initial effect, as well as from ‘resis-
tance’ to chemotherapy drugs [30,37–40]. Intriguingly, the combination
of anti-VEGF therapy with conventional chemotherapy has improved
survival in cancer patients compared with chemotherapy alone. These
seemingly paradoxical results have been explained by a ‘normalization’
of the abnormal tumor vasculature usually characterized by dilated, tor-
tuous, and hyperpermeable vessels. Vascular normalization leads to an
attenuation of hyperpermeability, increased vascular pericyte coverage,
amore normal basementmembrane, and a resultant reduction in tumor
hypoxia and interstitial ﬂuid pressure [41–43]. These in turn can lead to
an improvement in the metabolic proﬁle of the tumor microenviron-
ment, the delivery and efﬁcacy of exogenously administered therapeu-
tics, the power of radiotherapy and of effector immune cells, and a
reduction in number of metastatic cells. An omics approach in models
of EC normalization, taking into account also other stromal cells such
as ﬁbroblasts and immune cells, could shed more light on the mecha-
nisms underlying this promising effect. The putative contribution of
ICT in vascular normalization is unknown but the ﬁeld is in need of
alternative targets, related to the identiﬁcation of novel and missing
angiogenesis annotations and their association with vascularization by
the use of statistical analysis and multiple gene expression datasets.
GeneHits is a method that combines graph diffusion kernels from PPI
and pairwise associations from protein domain occurrence to construct
a global angiogenesis protein interaction network, called ‘Angiome’
[44,45]. An initial network of 478 proteins was then extended to
1233 proteins. The angiome allows one to identify those genes and
proteins in the databases that are associatedwith angiogenesis by com-
paring the disease- or condition-speciﬁc data to the angiome. Examples
may include identiﬁcation of speciﬁc angiogenesis-associated genes
that are up- or downregulated or mutated in disease conditions.
Some of them may then be considered as putative targets for thera-
peutic approaches that, ultimately, will need to be experimentally
validated. The human interactome was recently integrated with known
angiogenesis-annotated proteins to identify a set of 202 angiogenesis-
associated proteins in different cell lines [46]. The expression of several
proteins turned out to be highly perturbed during angiogenesis. Upon
exposure to VEGF-A, some proteins were upregulated, such as HIF-1α,
APP, HIV-1 tat interactive protein 2, and MEF2C, whereas endoglin,
liprin β1 and HIF-2α resulted downregulated. The analysis showed dif-
ferential regulation of HIF-1α and HIF-2α [46]. ‘Angiome’ database
doesn't include yet information about ICT, whose implementation will
hopefully cover this lack.
Despite the fact that these high-throughput and large-scale
approaches reveal very powerful and increasingly robust, they are still
poorly employed in the ﬁeld of membrane transport. Most of the avail-
able information on the differential expression pattern of transportome
2650 L. Munaron / Biochimica et Biophysica Acta 1848 (2015) 2647–2656is actually obtained from small-scale hypothesis-driven works. Two
well described examples involve somemembers of the Transient Recep-
tor Potential (TRP) channels and Orai1 that form calcium-permeable
channels. Among the 30 mammalian TRP channels, at least 19 are
expressed in vascular EC and are suggested to participate in a wide
range of vascular functions, including control of vascular tone, perme-
ability, mechanosensing, vascular remodeling and angiogenesis [47].
However, in spite of the large body of data available, the functional
role of many endothelial TRP channels in normal and neoplastic angio-
genesis is still poorly understood. Transient receptor potential vanilloid
4 (TRPV4) is a calcium channel involved in ECmigratory potential and is
overexpressed in human breast-carcinoma derived EC (BTEC) com-
pared to healthy EC [48]. Canonical transient receptor potential channel
1 (TRPC1), as well as another calcium channel, Orai1, is upregulated
in endothelial progenitor cells (EPC) isolated from renal carcinoma
patients compared with EPC from healthy patients [14,49,50]. Both
these cases will be largely discussed in the following chapter [12,13,
15–17]. Growing evidence supports the evidence that cancer cells may
drive endothelial changes by exploiting their high ﬂexibility. In particu-
lar, tumoral microenvironment has the ability to greatly inﬂuence the
drug-resistance of EC through molecular mechanisms still poorly
understood. A recent paper postulated that microvessels (MV) derived
from MCF-7 adriamycin-resistant cells (MCF-7/ADM) communicate
with and inﬂuence the resistance of HMECs acting as a ‘cargo’ in cell–
cell communication. MCF-7/ADM cell-derived MVs transfer TRPC5 to
HMECs, inducing the expression of P-glycoprotein (P-gp) by activation
of the transcription factor NFATc3 (nuclear factor of activated T cell iso-
form c3) [51]. The TRPC5-dependent upregulation of P-gp is suggested
to be tighly associated with Ca2+ entry induced by functional TRPC5
ion channel, but only further investigations will provide more mecha-
nistic details on this intriguingprocess: blocking TRPC5 could contribute
to overcome drug-resistance in cancer.
The altered expression panel of tumor-associated ICT does not
involve only calcium channels, as suggested by the aberrant level of
potassium channels encoded by the human ether-a-go-go related
gene (Kv11.1, or hERG1) that regulate vascularization in some human
cancers [52–54].
Another very interesting issue is related to the membrane perme-
ability for water. Among the membrane ﬂuxes that play a universal
and conserved role in cell physiopathology, water permeation is highly
relevant being a direct regulator of intracellular osmoticity and volume.
Aquaporins (AQPs) are the integral plasma membrane proteins in-
volved in water transport in many ﬂuid-transporting tissues. Cancer
cells express AQPs and a positive correlation exists between histological
tumor grade and the AQP expression [55,56]. In particular, AQP-1 plays
a crucial role in tumor angiogenesis and regulates ECmigration [57–61].
Deletion of AQP-1 in genetically modiﬁed mice reduces tumor angio-
genesis [57]. In AQP-1 knockout mice, implanted tumors grow slowly
and are less vascularized than in wild-type mice, indicating that cancer
neovascularization and growth are promoted by endogenous AQP-1. On
the other hand, the evidence that these mice develop normally with no
detectable vascular defects strengthens the idea that normal and tumor
angiogenesis are governed in different ways. Furthermore, microarray
analysis has revealed that the AQP-1 gene is upregulated by estrogen
and plays a crucial role in estrogen-induced tubulogenesis of HUVEC
possibly contributing to vascular permeability increase seen in response
to the hormonemediated by the upregulation of VEGF and its receptors
[60,62–64].
3. Interactomics of vascular ICT
3.1. Databases
A global map of protein–protein interactions (PPI) in cellular
systems provides key insights into how an organism works as a whole.
Indeed, human diseases are rarely the consequence of an isolatedabnormality in a particular gene but are usually the outcomeof complex
perturbations of the underlying molecular network. This has led to sys-
tematic studies of interactome networks, whose structure is governed
by key graph theoretical laws, where the probability of observing a pro-
teinwith a small number of interactions is higher than the probability of
observing a protein with many interactions [65].
Several public databases allow interactive investigation of interac-
tome, including String-db, Genehits, Uniprot, Biogrid, DIP, IntAct,
Reactome, Pathwayscommons, Pathway Interaction Database, and
Unihi [65]. A repository of well-validated high-quality PPI can be used
in both large- and small-scale studies to generate and validate a wide
range of functional hypotheses. The pattern of binary interactions can
be obtained by literature-curation (LC) and high-throughput experi-
ments (HT) [66]. LC refers to systematically collecting interaction data
from small-scale studies while HT experiments produce large-scale in-
teraction maps. Because most LC data are generated by hypothesis-
driven experiments, it is much easier to infer biological function from
those studies as compared to HT experiments [66].
Despite the quality of this approach being widely questioned, the
reproducibility of large-scale protein interaction results has much
improved. Moreover, common data standards and coordinated curation
practices between the databases that collect the interactions havemade
these valuable results available to awide community of researchers [65]
. Nonetheless, it is not easy to reconcile information fromdifferent inde-
pendent and not-coordinated sources. For this reason, a number of
them joined in International Molecular Exchange consortium (IMEx)
to provide a unique standard curation practice and data presentation
[67].
Interaction databases may lead to different predictions whose accu-
racy can be improved by incorporating datasets on organ- and cell type-
speciﬁc gene expression, and by obtaining additional independent ex-
perimental evidence [68]. A recent survey evaluated the characteristics
of six interaction databases, incorporated tissue-speciﬁc gene expres-
sion information and then investigated if the most popular proteins of
scientiﬁc literature are involved in good quality interactions [68]. The
databases result comparable in terms of node connectivity (i.e. proteins
with few interaction partners also have few interaction partners in
other databases), but may differ in the identity of interaction partners.
Moreover, the incorporation of tissue-speciﬁc expression information
signiﬁcantly alters the interaction landscape and many of the most in-
tensively studied proteins are engaged in interactions associated with
low conﬁdence scores.
An advanced systems biology of vascular ICT in angiogenesis aims at
investigating the network of physical and biochemical PPI at two levels:
the multimeric ICT assembly and, more broadly, PPI occurring between
membrane transportome and proteins canonically associated with
other functions such as cell signaling and metabolism. This second
level would help to explain how channels and transporters integrate
and coordinate intracellular pathways as well as how ICT are regulated
by signaling proteins, lipids, and gasotransmitters [69–75]. Accordingly,
defective interactions of protein partners with ICT represent alternative
mechanisms ofmembrane channelopathies [76].Molecular interactions
actually create local microenvironments that can modify the functional
properties of ICT. The assemblies built around a transporter or channel,
called ‘transportsomes’ and ‘channelosomes’, can be considered as func-
tional units even if they are difﬁcult to purify and reconstitute, posing a
signiﬁcant challenge in the investigation of their functional role [77,78].
A special issue on ‘Channels’ provides an overview of the nature and
function of transportsomes and channelosomes [77]. Successful studies
focusing on PPI could potentially lead to new drug discovery strategies
targeting ion channel complexes [79].
As alreadymentioned, the interactomedynamics is strictly related to
the physiological or altered cellular targeting of ICT. Indeed, the actual
functions and biological effects of ion-transport-related proteins
critically dependupon their intracellular distribution and, consequently,
their interaction with a speciﬁc pattern of other proteins (speciﬁc
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protein (ﬁrst-order) binding detectable by yeast-two-hybrid and pro-
tein complementation assays, as well as to indirect interaction through
the mediation of other components, including scaffolding proteins,
detectable by afﬁnity puriﬁcation followed by mass spectrometry [65].
In some cases PPI are associated with post-translational modiﬁca-
tions that drive cell signaling, such as phosphorylation, nitrosylation,
sulphydration, redox reactions, and palmitylation.
According to this well-established knowledge, a more integrative
view of ICT is now required, that should be investigated as components
of the global vascular proteome involved in angiogenesis. The applica-
tion of such a systems biology approach, that is experiencing its initial
stage in this particular ﬁeld, will hopefully open new exciting directions
in both basic and biomedical biology.
3.2. Angiogenesis-related channelosomes
Among the channels that play remarkable roles in tumor vasculari-
zation, the aforementioned Transient Receptor Potential (TRP) proteins
are the best known and their functions are regulated through interac-
tion with many cellular proteins [70,80,81]. The TRIP (Transient recep-
tor potential channel-Interacting Protein) manually curated database
has been recently developed, that aims to offer comprehensive informa-
tion in the ﬁeld [78,82,83]. According to the broad considerations
discussed in the previous chapter on interactome databases, great
attention should be devoted in order to extract suitable unbiased infor-
mation. Indeed, not all TRPs and their interactors are simultaneously
expressed in a cell; PPI may occur only in a speciﬁc biological microen-
vironment; a TRP-binding protein concurrently interacts with multiple
TRPs in a given cell at a speciﬁc condition; moreover, TRP-interacting
proteins may competitively bind to the same region of a TRP channel.
Given that interactions can dynamically modify the activities and sub-
cellular locations of TRP, cell type- or cell context-speciﬁc PPI data are
required to reveal the physiological relevance of TRP interactome in a
more integrated viewpoint. Such data can be harvested by omics exper-
imental approach under cell type- or cell context-speciﬁc conditions or
computational integration of TRP channel PPI datawith gene expression
proﬁle data.
TRP channels assemble into homomeric or heteromeric tetramers
[84]. The latter complexes are formed among the isotypes within or
across subfamilies, suggesting a high-order complexity of TRP channel
regulation in a physiologic context. Though not fully characterized,
some evidence shows that new biophysical properties are created by
heteromerization between TRP channel isotypes, including TRPC1–
TRPC3, TRPC1–TRPC4, TRPC4–TRPC5, TRPC1–TRPC5, TRPC1–TRPP1,
TRPC1–TRPV4, TRPV4–TRPP1, TRPV5–TRPV6, TRPML1–TRPML2, and
TRPML1–TRPML3 [84,85]. TRPC1 interacts physically with TRPV4 to
form a complex thatmediatesﬂow-induced and store-operated calcium
entry (SOCE) in primarymouse aortic and humanHUVEC [86,87]. Endo-
thelial SOCE involves signalplexes embodying Orai1, Stim1 and TRPC1
and regulates critical vascular processes, remodeling and angiogenesis
[85,88].
Functional SOCE is also present in human circulating endothelial
progenitor cells (EPCs), a sub-population of mononuclear cells
that is recruited from either bone marrow or arterial wall to replace
damaged/senescent EC and recapitulate the vascular network of le-
sioned organs. They act by either stimulating local angiogenesis via
paracrine signaling or by physically engrafting within neovessels.
SOCE controls proliferation and in vitro tubulogenesis in EPCs isolated
from both peripheral and umbilical cord blood of healthy donors (N-
EPC). Notably, SOCE is upregulated, mitogenic and protubulogenic for
EPCs isolated fromperipheral blood of patients affected by renal cellular
carcinoma (RCC-EPC) [14,49,50,89]. The enhanced SOCE in these cells is
associated with the over-expression of Stim1, Orai1, and TRPC1 [49,50,
89]. N-EPCs possess TRPV4, which plays a master signaling role in
mature healthy and tumor-derived endothelium, by controlling bothvascular remodeling and arterial pressure [90]. TRPV4 mediates cell
migration of BTEC (but not HMEC) via arachidonic acid-activated actin
remodeling [91]. The role of TRPV4 in EPC is unknown, but it is not
involved in the control of cell proliferation [90]. Surprisingly, both
N-EPC and RCC-EPC lack TRPC3, TRPC5 and TRPC6 that play critical
functions in mature endothelium [11,12,16,17]. Endothelial colony
forming cells isolated from patients with primary myeloﬁbrosis
(PMF-ECFCs) undergo a distinctive remodeling of the Ca2+ machin-
ery: Stim1, TRPC1, TRPC4, Orai3 and, perhaps, Orai2 proteins are up-
regulated and, unlike N- and RCC-ECFC, the InsP3-dependent SOCE
does not drive PMF-ECFC proliferation [92].
An overviewof the current state and future directions of TRP channel
network biology is reported in [78].
3.3. Interactions between ICT and cytoskeleton
Some ion channels and transporters bind to members of the large
family of proteins that constitute the cytoskeleton [21,93]. This sub-
network underlies the endothelial mechanosensitivity and transduction
during sprouting angiogenesis [21,94,95].
3.3.1. TRP channels
TRP channels selectively associate with the cytoskeleton [96]. Many
of them include ankyrin repeat domains, 33-residuemotifs consisting of
pairs of antiparallel α-helices connected by β-hairpin motifs, that link
proteins, such as InsP3R or NHE, to the cytoskeleton. The occurrence
of such domains is differently pronounced within the TRP family but
their function is still poorly understood [70]. The relationship between
TRP proteins and cytoskeleton is bidirectional, with a role of ion ﬂuxes
in the rearrangement of the cytoskeleton structures and, in turn, the
activity of the cytoskeleton and associated proteins in supporting the
appropriate TRP targeting, PPI and channel gating [96].
Furthermore, TRP channels are part of macromolecular complexes
including different signal transduction proteins involved in a variety of
cell functions [77]. A relevant example is the role of the scaffolding pro-
teins belonging to the families of Homer and INAD that regulate TRPC
channel gating [96]. Intriguingly, TRP themselves can act as scaffolding
proteins. Recent analysis of the function of TRPC4 in vascular EC of
divergent phenotype revealed a novel aspect of TRPC signaling, extend-
ing the current concept of TRPC regulation by a phenotype-dependent
switch between Ca2+ transport and a potential intracellular scaffold
function of the TRPC protein [97]. TRPC4 contains six transmembrane
domains and its cytosolic C terminus includes several binding domains
that tether TRPC4 to the membrane skeleton. A functional mammalian
INADhomologous proteinwas identiﬁed by the characterization of pep-
tide sequences of NHE Regulatory Factor (NHERF) and the subsequent
identiﬁcation of TRPC4 and TRPC5 as potential interaction partners
[98]. NHERF was originally isolated as a factor required for inhibition
of NHE type 3 (NHE3) mediated by PKA [99]. The protein has two PDZ
domains, the ﬁrst one recognizing peptides carrying T-R-L at the
C-terminus. The sequences of the mammalian TRPC4 and TRPC5 also
end with the T-R-L motif. The activation mode of the TRPC4/5 complex
is still an issue of controversy. Some groups proposed a store-depletion
mechanism,while other laboratories reported the activation of TRPC4/5
to be dependent on receptor/G-protein/PLC activation, but independent
of store depletion [100]. PDZ1 of NHERF1 binds to TRPC4 and TRPC5
heterologously expressed proteins [98]. The interaction of two partners
with the same PDZ domain suggests a model in which NHERF forms a
homodimer via PDZ2 and PDZ1 domains, bringing TRP channels
(TRPC4, TRPC5) in proximity of PLC [98]. Like INAD, which controls
function, stability, and plasma membrane expression of Drosophila
TRP, NHERF regulates TRPC4 targeting.
A model of TRPC4 embedded in its signaling scaffold has been
proposed in pulmonary artery EC (PAEC) [101]: TRPC4 interacts directly
with protein 4.1 through its protein 4.1 binding domain, as well as with
NHERF, linked to actin through ezrin–radixin–moesin (ERM) proteins.
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and G-protein-coupled receptors through its PDZ domains. The sig-
naling assembly is localized in cholesterol-rich caveolae containing
caveolin-1, a binding partner for different ion channels (see below)
[101]. In the same cells TRPC4/Orai1 coupling controls TRPC1/4 activa-
tion and channel permeability, including Ca2+ selectivity, and the ensu-
ing endothelial cell barrier function [102,103]. It is worth noting that,
although Orai1 expression is usually associated with its canonical func-
tion as a Ca2+ channel, growing evidence suggests that Orai1 and Orai3
proteins may be more important than Ca2+ inﬂux to control prolifera-
tion of different cell lines [104]. Intriguingly, thrombin-mediated
decrease of transendothelial electric resistance (TER), amarker of endo-
thelial barrier disruption, requires Stim1 independently of Orai1 and
Ca2+ entry across the plasma membrane in HUVECs and HMVECs. The
regulation of endothelial barrier function may not be due to Stim1-
mediated interactionwith TRPC channels. Rather, Stim1 seems to be re-
quired for RhoA activation, MLC phosphorylation, and formation of
actin stress ﬁbers [105]. Other TRPC4 interactors are the largemolecular
weight immunophilins FKBP51 and FKBP52 that respectively inhibit
and enhance TRPC4-related SOCE in PAECs [106]. As discussed below,
TRPC4 is critically involved in the regulation of EC permeability by
Thrombin [107]. In HMEC TRPC4 is regulated by cell–cell contact forma-
tion and interacts with β-catenin, and the related Ca2+ entry acts in a
speciﬁc endothelial state during the transition from a proliferating to a
quiescent phenotype. Hence TRPC4 may adopt divergent functions in
endothelial Ca2+ homeostasis and emerges as a potential key player
in endothelial phenotype switching and tuning of cellular growth factor
signaling [108].
Cyclic mechanical strain produced by pulsatile blood ﬂow regulates
the orientation of EC lining blood vessels and contributes to the control
of angiogenesis. It has been reported that ﬂow-induced stretching acti-
vatesmechanosensitive TRPV4 that, in turn, stimulates PI3K-dependent
activation and binding of additional integrin receptors, which promotes
cytoskeleton remodeling and cell reorientation. Inhibition of integrin
activation using blocking antibodies and knockdown of TRPV4 channels
with speciﬁc siRNA suppress strain-induced capillary cell reorienta-
tion [109]. A direct interaction between TRPV4, α2 integrin and
the Src tyrosine kinase Lyn has been reported in sensory neurons
[110], raising the possibility that TRPV4 could reside in a common
mechanosignaling complex with extracellular matrix (ECM) receptors
also in the endothelium.
Other interactors of integrins are potassium channels. In particular,
hERG1 are frequently found aberrantly expressed in tumors (see
above) and control different aspects of the neoplastic cell physiology:
they trigger and modulate intracellular signaling cascades through the
assembly of multiprotein membrane complexes which also recruit
integrin subunits and receptors for growth factors or chemokines [52,
53,111]. Therefore, hERG1 may be a key component of the ‘functional
hubs’ that control angiogenesis in cancer. The microenvironment,
through the functional interplay between integrins and hERG1, regu-
lates angiogenesis and tumor progression possibly contributing to
VEGF resistance [13,52,111,112]. A signaling pathway that sustains
angiogenesis and progression in colorectal cancer cell lines has been
proposed in which β1 integrins and hERG1 channels form a functional
plasma membrane complex able to recruit and activate PI3K and
Akt. This event in turn increases the Hypoxia Inducible Factor (HIF)-
dependent transcription of VEGF-A and other tumor progression
genes. Similarly, VEGFR-1 (FLT-1), β1 integrin, and hERG form amacro-
molecular signaling complex in acute myeloid leukemia [113].
3.3.2. Aquaporins
As mentioned before, water ﬂuxes mediated by Aquaporins are in-
volved in tumor angiogenesis. Presumably AQP1, which is speciﬁcally
and strongly expressed in most EC of the microvasculature outside the
brain [114], seems to act not only as a water channel but it contributes
to cell migration [57,115]. In two different cell lines expressing AQP1,the human melanoma cell line WM115 and the human microvascular
cell line HMEC, the knock down of AQP1 promotes a re-organization
of F-actin and affects the cell shape [115]. In non-silenced cells F-actin
is preferentially polarized at the leading edge of the plasma membrane
and the cells produce tubules in vitro [115]. In contrast, AQP1-silenced
cells loose signiﬁcantly their tubulogenic potential and decrease their
ability to migrate [115]. Actually, the polarization at the leading edge
of migrating cells has been demonstrated for several transporters in-
volved in migration, including Na+/H+ and Cl−/HCO3− exchangers and
the Na+/HCO3− co-transporter, and cell migration involves the transient
formation of lamellipodia and plasma membrane rufﬂes at the leading
edge of the cell, suggesting that rapid local changes in ion ﬂuxes and
cell volume are accompanied by rapid transmembrane water move-
ment [116]. Thereby, the actin cleavage and ion uptake at the tip of
the lamellipodium might create local osmotic gradients that drive the
inﬂux of water across the plasma membrane. Saadoun et al. postulated
that water entry increases local hydrostatic pressure causing the polar-
ization of AQP1 [57]. The intracellular mechanisms triggered by AQP1
are not well known, but it has been recently shown that Lin-7 co-
immunoprecipitates with AQP1 and interacts with β-catenin through
Lin-7, affecting the organization of cytoskeleton [115]. Intriguingly, the
lack of AQP1 leads the Lin-7/ β-catenin complex to proteolytic degrada-
tion [115]. Altogether, these data suggest that the physiological role of
AQP1 goes beyond its water transport function. This protein rather
emerges as a critical scaffold for a plasma membrane associated multi-
protein complex critical for endothelial cytoskeleton build-up, adhesion
and motility [115].
3.4. Other TRP interactors
A number of interacting proteins bind to different TRP members,
such as caveolin 1, calmodulin, Src, and IP3 receptor 3 (IP3R3). This
sub-network offers the potential functional link to human diseases.
For example, the oncogene Src interacts with nine TRP members, in-
cluding TRPV1, TRPC6 and TRPV6: all of them are associatedwith cancer
progression and the ﬁrst two with tumor angiogenesis [12,16,17,78].
Caveolin-1 is a particular plasma membrane binding partner for a
number of ion channels. A work conducted on HMEC and endothelium
fromCAV-1−/−mice reported that Cav-1 scaffold domain interactswith
TRPC1 and IP3R3 to regulate SOCE [117,118]. TRPC1 is embedded in a
protein complex that can include IP3R, homer, calmodulin, caveolin-1,
FKBP25, I-mfa, MxA, GluR1α, bFGFR-1, Gq/11 protein, phospholipase
C-β/γ, protein kinase C-α and RhoA [119].
An integrated functional example is given by the role of TRPC1 in the
regulation of thrombin-mediated endothelial permeability. Thrombin
binds to the endothelial surface protease-activated receptor-1 (PAR-1)
triggering a signaling cascade that results in the development of inter-
endothelial junctional gaps that ﬁnally lead to an increase in endothelial
permeability, the hallmark of tissue inﬂammation [120,121]. The for-
mation of these gaps is the result of cell–cell contact alteration: in
particular, Ca2+ signaling is critical for PKCα activation in mediating
disassembly of VE–cadherin junctions [122,123]. Endothelial perme-
ability is also decreased through a cell shape change induced by
actinomyosin-mediated endothelial contraction: this endothelial
‘rounding up’ is mediated by Ca2+ entry via TRPC1 mediated by the
monomeric GTP-binding protein RhoA [124]. In summary, Rho activa-
tion signals interaction of IP3Rwith TRPC1 at the EC plasmamembrane,
and triggers Ca2+ entry following IP3-dependent store depletion
(SOCE) and the resultant increase in endothelial permeability [124]. It
has been reported a similar causal link between the Gq-mediated
increase in cytosolic Ca2+ via TRPC6 and activation of RhoA, ﬁnally lead-
ing to the increase in endothelial permeability in response to Thrombin
[125]. This is an intriguing example involving an unusual scaffolding
protein, phosphatase and tensin homologue (PTEN). PTEN is a dual
lipid-protein phosphatase that catalyzes the conversion of PIP3 to PIP2
and inhibits PI3K–Akt-dependent cell proliferation, migration, and
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pressing PI3K signaling: in HPAEC it serves as a scaffold for TRPC6
through residues 394–403, enabling cell surface expression of the chan-
nel [126].
TRPC4-dependent Ca2+ entry is another critical determinant of
this process: indeed, both Ca2+ entry and lungmicrovascular perme-
ability in response to Thrombin are drastically reduced in TRPC4−/−
mice [127]. In addition to TRPC1, TRPC6 and TRPC4, also themelastatin-
family transient receptor potential 2 (TRPM2) channel regulates vas-
cular permeability. TRPM2 is an oxidant-sensitive Ca2+ permeable
channel that mediates H2O2-induced Ca2+ entry and endothelial
hyperpermeability [128]. Oxidants generated by activated EC are
also known to induce apoptosis, a pathogenic feature of vascular injury
and inﬂammation from multiple pathogeneses. The proapoptotic sig-
naling mechanism involves reactive oxygen species-induced protein
kinase C-α activation resulting in phosphorylation of the short splice
variant TRPM2 (TRPM2-S) that allows enhanced TRPM2-mediated gat-
ing of Ca2+ and triggers the apoptosis program. Strategies aimed at
preventing the uncoupling of TRPM2-S from TRPM2 and subsequent
Ca2+ gating during oxidative stress may mitigate endothelial apoptosis
and its consequences in mediating vascular injury and inﬂammation
[129]. Oxidative stress also increases the expression of TRPM7. This pro-
tein has the peculiar dual ability to act as a magnesium/calcium perme-
able channel and as a kinase through its functional α-kinase domain at
the carboxyl terminus. For this reason it has been called, together with
TRPM2, ‘chanzyme’ [130]. TRPM7 permeability for Mg2+ is intriguing:
in particular, an inhibitory effect of hypomagnesaemia on tumor growth
and neoangiogenesis is under investigation [131]. TRPM7 channels are
expressed and functional in human EC. InHMEC lowMg2+ inhibits pro-
liferation and migration without affecting metalloprotease production
and tridimensional organization: this effect is mediated, at least in
part, by the decrease of TRPM7, since its silencing mimics the effects
of Mg deﬁciency, thus suggesting TRPM7 as a possible contributor to
the regulation of angiogenesis [132]. The opposite effect has been ob-
served in HUVEC: two independent reports have shown that siRNAs
transiently silencing TRPM7 stimulate cell proliferation, a behavior
which is unique to HUVEC, because in other cell types the samemanip-
ulation induces cell cycle arrest. In addition to the signiﬁcant elevation
of TRPM7 in the vasculature of MgL mice (a model of inherited hypo-
magnesemia), the increase of TRPM7 transcript in HUVEC exposed to
shear stress has been described [133]. TRPM7 silencing promotes endo-
thelial growth/proliferation and nitric oxide production via the ERK
pathway [134]. The enzymatic kinase activity of TRPM7might inﬂuence
the ERK pathway although it is still not clear whether inhibition of
TRPM7 channel also affects its kinase activity.
Another ion channel interactor is the superfamily of G-proteins that
are particularly relevant as a physical link to cell signaling [135]. An
interesting example is provided by the metabotropic glutamate
receptor-1 (mGluR1) that may play a key role in regulating EC phe-
notype during tumor-induced angiogenesis. A loss of mGluR1 expres-
sion and activity is associated with an anti-angiogenic phenotype and
tumor suppression [136]. Despite the lack of information on PPI
between mGluR1 and endothelial transportome this interaction seems
likely since in Purkinje cells mGluR1 is physically associated and
activates TRPC1 [137].
3.5. Interactions between channels and transporters
The functional/physical coupling of ion channels with trans-
porters seems to contribute to the neovascularization of healthy
and tumoral tissues. Some examples involve Na/Ca (NCX) and Na/H
(NHE) exchangers, two broadly expressed carriers that regulate in-
tracellular calcium and proton homeostasis respectively [138–140].
In transfected HEK cells Na+ entry mediated by TRPC3 enables
local Na+ accumulation that drives Ca2+ entry via reverse mode
NCX. This functional interaction is probablymediated by a tight physicalinteraction between TRPC3 and NCX1, suggesting a close spatial prox-
imity between these ion transport systems [141,142]. In EC from
excised rat aorta the reverse mode NCX mediates, in cooperation with
ATP-sensitive potassium channels, KATP, calcium signals activated by
hydrogen sulﬁde, a gaseous bioactive messenger that has been impli-
cated in tumor angiogenesis [74,141,142]. Intriguingly, reversemode
NCX could also be triggered by voltage-dependent sodium channels in
endothelium. Voltage-gated Na+ channels (NaV) have long been con-
sidered as being characteristic of excitable cells: however, different
NaV isoforms have been found in non-excitable cancer cells and their
function enhances cancer cell invasiveness [145,146]. Nav 1.5 isoform
is expressed and functional in HUVEC andmediatesmultiple angiogenic
functions. In particular, it adjusts membrane potential and potentiates
VEGF-induced ERK1/2 activation through the PKCα-B-RAF signaling
[74,143,144]. Accordingly, Ca2+ inﬂux through reverse mode NCX is
also required for the activation and targeting of PKCα to the plasma
membrane, an essential step for VEGF-induced ERK1/2 phosphorylation
and downstream EC functions in angiogenesis [147]. Whether the
voltage-gated sodium channel contribution to agonist-induced ERK1/2
activation is speciﬁc to VEGF and EC remains to be elucidated.
In addition to NCX, voltage-gated sodium channels can also interact
with theNa+/H+ exchanger NHE1. In highly invasive breast cancer cells
and high-grade breast cancer biopsies, the overexpression of the NaV1.5
isoform has been associated with extracellular matrix remodeling and
the increased probability of developing metastases [145,146,148]. The
proteolytic activity of invadopodia is highly dependent on the acidiﬁca-
tion of the peri-invadopodial extracellular compartment through the
localized activity of NHE1 [140,149,150]. NHE1 is known to have a sub-
stantial role in extracellular acidiﬁcation and in the invasiveness of can-
cer cells. In highly invasive breast cancer cells MDA-MB-231, NaV1.5
interacts with and allosterically increases NHE1 activity in a pHi range
between 6.4 and 7.0: this interaction is localized in focal ECM degrada-
tion sites corresponding to caveolin-1-containing invadopodia [148].
In addition, NaV1.5 activity controls Src kinase activity, cortactin phos-
phorylation and actin cytoskeleton dynamics [148]. NHE1 may be
directly involved in angiogenesis. HIF-1 overexpression upregulates
VEGF, NHE1 and calpains in HUVEC and thus enhances endothelial pro-
liferation, migration, and tube formation [151]. Furthermore, suppres-
sion of NHE1 reduces calpain-2 expression and activity, ﬁnally leading
to inhibition of HIF-1-induced angiogenesis. In addition to its canonical
function, NHE1 can act as an anchor for actin ﬁlaments to control the
integrity of the cortical cytoskeleton [152]. This occurs through a struc-
tural link betweenNHE1 and the actin-binding proteins ERM. NHE1 and
ERM proteins associate directly and colocalize in lamellipodia. Notably,
ﬁbroblasts expressing NHE1 with mutations that disrupt ERM binding,
but not ion translocation, have impaired organization of focal adhesions
and an irregular cell shape. It could be interesting to investigate non-
canonical NHE activities in angiogenesis.
Finally, although nodata are available so far concerning the potential
interaction between ICT and ion pumps as a component of angiogenic
signaling, in other tissues some examples have been reported. In the
brain and kidney TRPC6 and the Na+/K+ ATPase are part of a functional
complex that may be involved in ion transport and homeostasis [153].
4. Conclusions
The post-genomic era is witnessing an explosive accumulation of
biological data. At the same time, several public databases offer the
opportunity to access such a wide range of biologically relevant liter-
ature on biomolecules and their expression, structure, location and
interaction with other biological components. These novelties have
attracted research focus towards data analysis and mining, in which
the extraction of robust and suitable information from sparse and
non-homogeneous sources is currently the main challenge. We often
look at data- and hypothesis-driven methods as dichotomic strategies
because they are hard to be integrated. Data-driven methods afford
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biological phenomena but they are difﬁcult to be combined to perform
controlled experiments for testing hypotheses and, thus, to solve
speciﬁc questions in biology. Therefore, the protein–protein network
approach is a promising alternative that allows us to formulate test-
able hypotheses and to design validating experimental settings. In addi-
tion, since physiological and altered functions are regulated across
many orders of magnitude in space and time, quantitative computa-
tional multi-scale modeling is increasingly adopted by researchers as a
valuable descriptive and predictive tool in systems biology [154–158].
Unfortunately, the systems biology viewpoint is still poorly employed
in the biology of transportome in cancer. A simple explanation of the
delay is that the research focused on membrane transport has been
far from the ﬁeld of experimental oncology for long time. Only very
recently these two domains converged and an increasing amount
of experimental data is currently available on canonical and non-
canonical roles of ion channels in tumor vascularization. Thus, ICT are
still under-represented in interactomic databases when compared to
other protein families with a longer tradition in oncology (receptors,
kinases, phospholipase, transcription factors and others). Consequently,
very few human proteins involved in membrane transportare anno-
tated as components of cancer- and angiogenesis-associated signal-
ing pathways, with the partial exception of TRP channels.
More theoretical and experimental effort will be needed to acquire a
network perspective of transportome hopefully leading to a signiﬁcant
advancement in basic biology and oncology.References
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